The mortality risk may be impacted by Canada's less widespread availability of TAVR for the treatment of aortic stenosis compared to the US.

Published Date: 26 Apr 2023

According to a recent study, Ontario and New York State have very different access to transcatheter aortic valve replacement (TAVR) and patient outcomes. Access to TAVR and had improved for New Yorkers.

Read Full News

Latest News

Aortic valve size determines the degree of valve calcification in severe aortic stenosis, finds study

Recent research from Karl Landsteiner University of Health Sciences (KL Krems) provides important new insights into how aortic valve size is associated with the degree of valve calcification in severe aortic stenosis (AS).

Popular weight loss drugs bring unexpected heart health benefits—researchers discuss implications

Weight loss drugs like Ozempic deliver more health benefits than expected.

20-year study is the first to show food insecurity raises risk of heart disease over time

Struggling to afford food today could mean heart problems tomorrow. Young adults experiencing food insecurity have a 41% greater risk of developing heart disease in midlife, even after accounting for demographic and socioeconomic ...

Weight loss increases risk of death for obese adults

New research has found for the first time that extreme weight fluctuations in obese individuals with cardiovascular disease significantly increases the risk of death—with weight loss as well as weight gain raising risk ...

Expanding imaging for cardiac health to more patients

Imaging is a vital tool for assessing the health and strength of the heart. In two recent studies, Yale researchers have explored how to bring critical imaging to more people and how to expand its application.

Minimal TV viewing may be protective for heart disease linked to type 2 diabetes, study finds

Watching no more than one hour of TV a day may lower the risk of heart attack, stroke and other blood vessel diseases among people with varying levels of genetic risk for type 2 diabetes, including high genetic risk, according ...

Todays News

Robert F. Kennedy Jr. downplays measles vaccine as cases surge

A growing measles outbreak has led to 222 reported cases across Texas, New Mexico and Oklahoma in 2025, with health officials urging more people to get vaccinated.

Measles case at Dulles stresses the importance of vaccination

It's a nightmare scenario for public health officials: a traveler infected with a highly contagious virus passes through an airport while asymptomatic, unknowingly transmitting the disease to others and sparking a widespread ...

Experts bust 5 myths about living kidney donation

More than 90,000 people are on the waiting list for a kidney in the U.S. Unfortunately, less than a third of those waiting for a kidney transplant can expect to get one this year. This comes as rates of chronic kidney disease, ...

A physical therapist's best advice on foot pain

For nurses, servers, construction workers, and many others, work means a lot of time on their feet. Repeated motions can lead to muscle, nerve, or tendon stress. A split-second equipment slip can outmatch steel-toed boots ...

Exercise key to improving sexual dysfunction for patients with prostate cancer, study says

New research from Edith Cowan University (ECU) has confirmed that erectile dysfunction in patients living with prostate cancer could be significantly improved through regular exercise.

Statins and aspirin may impact muscle health in smokers

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study. The study is published in the January 2025 issue of ...

Young, active patients who have total knee replacements unlikely to need revision surgery in their lifetime

A 40-year study by Hospital for Special Surgery (HSS) researchers has found that active young adults who underwent total knee replacement were unlikely to require knee replacement revision in their lifetime, according to ...

Latest News

Weight loss drugs like Ozempic deliver more health benefits than expected.

The disparities between men and women in prevalence, risk factors and symptoms of peripheral vascular disease (PVD) have a profound impact on prevention, diagnosis, treatment and outcomes for women, according to a new American ...

Researchers from an international collaborative team have found that prehospital resuscitative thoracotomy (RT) is feasible and associated with improved survival for traumatic cardiac arrest (TCA) patients when performed ...

A new study reveals social isolation and loneliness can adversely affect mental and physical health, with researchers from the University of Wollongong (UOW) calling on Australians to look out for those who might be at risk.

Among postmenopausal women with a history of cancer, taking more daily steps and engaging in moderate-to-vigorous physical activity were both associated with a significantly reduced risk of death from cardiovascular disease, ...

Cardiovascular disease is a general term that refers to many different types of heart problems.

Alexis discussed the latest research in the field and new management strategies for children with atopic dermatitis.

Metz shared highlights from 2 presentations he gave on barzolvolimab’s efficacy at the AAAAI/WAO Joint Congress.

John Barbieri, MD, MBA, discusses recent data examining factors associated with formation of benzene in OTC benzoyl peroxide products.

This summary, featuring 4 leading experts, provides an overview of what dermatologists may look forward to during the AAD 2025 Annual Meeting.

Casale discussed data from the phase 1b/2a BEACON study he presented at the AAAAI/WAO Joint Congress.

News All Time

Survey Suggests Lack of Awareness, Treatments for Chronic Hand Eczema

In these survey findings, a variety of notable findings regarding perceptions of awareness of CHE as well as views on available drugs are highlighted.

Confirming Tapinarof’s Efficacy and Safety Across Atopic Dermatitis Severities, with Justin Greiwe, MD

Greiwe discussed findings from the phase 3 ADORING 1 and 2 trials in people as young as 2 years of age.

Phase 3 Data Supports Dupilumab’s Approval for CSU, with Thomas Casale, MD

Casale discussed data from the phase 3 LIBERTY-CSU CUPID studies evaluating dupilumab’s use in urticaria.

Questions About Dermatology Residency Applications, with the Skin of Color Society

A panel discussion at the Skin of Color Society Scientific Symposium features 3 notable speakers highlighting dermatology residency questions and more.

Key Questions About the Skin of Color Society’s Efforts This Year, with Crystal Aguh, MD

In this interview, Aguh answers several key questions about the efforts of the Skin of Color Society and improving diversity in clinical research.

Investigating Markers of Early-Onset Atopic Dermatitis, with Amy Eapen, MD

Eapen discussed her research into analyzing the cord blood methylome for markers that predict atopic dermatitis risk at the AAAAI/WAO Joint Congress.

Tirbanibulin Reduces Actinic Keratosis Lesions, Achieves High Patient Satisfaction

Combined analysis of data from a pair of post-registrational studies demonstrate the clinical profile and patient opinion on treatment with tirbanulin.

Improving Understanding of Molluscum Contagiosum Treatment, with Nanette Silverberg, MD

In this interview at AAD 2025, Silverberg discusses important facts for dermatologists to know in the management of molluscum contagiosum.

GLP-1 RAs Could Improve Outcomes in Central Centrifugal Cicatricial Alopecia

Susan Taylor, MD, discusses a study examining the effect of GLP-1 RA use relative to nonuse in central centrifugal cicatricial alopecia at AAD 2025.

Discussing New Phase 3 Data on Nemolizumab for Prurigo Nodlaris, with Sonja Ständer, MD

This AAD 2025 interview features a discussion with Sonja Ständer, MD, new phase 3 findings from OLYMPIA 1 and 2 on nemolizumab in patients with prurigo nodularis.

Discussing Treatments, Anticipatory Guidance for Molluscum Contagiosum, with Nanette Silverberg, MD

In this segment of Silverberg’s interview, she highlights providing anticipatory guidance for parents of children with molluscum as well as treatment options.

AAD 2025: Lebrikizumab Effective in Atopic Dermatitis for Up to 3 Years

New 3-year data from ADjoin demonstrate the efficacy and safety profile of lebrikizumab in moderate to severe atopic dermatitis.

Tapinarof Cream 1% Maintains Clear Skin for 80 Days in Atopic Dermatitis, with David Rosmarin, MD

David Rosmarin, MD, discusses results from ADORING 3 presented at AAD 2025.

Ruxolitinib Cream 1.5% Shows Promise for Prurigo Nodularis at AAD 2025

Phase 3 data from ruxolitinib cream 1.5% presented at AAD 2025 demonstrate the potential of the topical agent in prurigo nodularis.

Late-Breaking Data on Tapinarof Cream for Atopic Dermatitis, with Linda Stein Gold, MD

Stein Gold highlights her team's findings on tapinarof cream (Vtama) 1% from the 48-week ADORING 3 extension for those aged 2 to 17 with atopic dermatitis.

Latest Updates in Medical/Healthcare Sector

Formaldehyde Causes More Cancer Than Any Other Toxic Air Pollutant

Pressing the Sleep button could have a positive impact on cognition.

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment

The Cutting-Edge of Phlebectomy: Redefining Vein Care

Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment

Understanding the Importance of Red Cell Distribution Width (RDW) in Blood Tests

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates

European Cancer and Oncology Congress 2025

Multidisciplinary Update in Breast Disease 2024

10th Mayo Clinic Symposium on Immuno-Oncology and Tumor Microenvironment Crosstalk 2024

International Conference on Surgical Oncology Nursing (ICSON-25)

13th Annual New Therapeutics in Oncology: The Road to Personalized Medicine

Role of TNF alpha inhibitors and JAK inhibitors in rheumatological diseases

Newer advances in treatments: JAK Inhibitors

An overview of short stature and Turner's syndrome

LUNGIVITY- Is it time raise the bar for ALK rearranged NSCLC?

Exploring Advanced Homeopathic Therapies for Dysmenorrhoea

Participate and win cash vouchers

Get updates on the latest conferences happening around the world

Terms & Conditions | Privacy Policy | About Hidoc Dr

By using this site, you agree with our use of cookies.

The mortality risk may be impacted by Canada's less widespread availability of TAVR for the treatment of aortic stenosis compared to the US.

Latest News

Aortic valve size determines the degree of valve calcification in severe aortic stenosis, finds study

Popular weight loss drugs bring unexpected heart health benefits—researchers discuss implications

20-year study is the first to show food insecurity raises risk of heart disease over time

Weight loss increases risk of death for obese adults

Expanding imaging for cardiac health to more patients

Minimal TV viewing may be protective for heart disease linked to type 2 diabetes, study finds

Todays News

Robert F. Kennedy Jr. downplays measles vaccine as cases surge

Measles case at Dulles stresses the importance of vaccination

Experts bust 5 myths about living kidney donation

A physical therapist's best advice on foot pain

Exercise key to improving sexual dysfunction for patients with prostate cancer, study says

Statins and aspirin may impact muscle health in smokers

Young, active patients who have total knee replacements unlikely to need revision surgery in their lifetime

Latest News

News All Time

Survey Suggests Lack of Awareness, Treatments for Chronic Hand Eczema

Confirming Tapinarof’s Efficacy and Safety Across Atopic Dermatitis Severities, with Justin Greiwe, MD

Phase 3 Data Supports Dupilumab’s Approval for CSU, with Thomas Casale, MD

Questions About Dermatology Residency Applications, with the Skin of Color Society

Key Questions About the Skin of Color Society’s Efforts This Year, with Crystal Aguh, MD

Investigating Markers of Early-Onset Atopic Dermatitis, with Amy Eapen, MD

Tirbanibulin Reduces Actinic Keratosis Lesions, Achieves High Patient Satisfaction

Improving Understanding of Molluscum Contagiosum Treatment, with Nanette Silverberg, MD

GLP-1 RAs Could Improve Outcomes in Central Centrifugal Cicatricial Alopecia

Discussing New Phase 3 Data on Nemolizumab for Prurigo Nodlaris, with Sonja Ständer, MD

Discussing Treatments, Anticipatory Guidance for Molluscum Contagiosum, with Nanette Silverberg, MD

AAD 2025: Lebrikizumab Effective in Atopic Dermatitis for Up to 3 Years

Tapinarof Cream 1% Maintains Clear Skin for 80 Days in Atopic Dermatitis, with David Rosmarin, MD

Ruxolitinib Cream 1.5% Shows Promise for Prurigo Nodularis at AAD 2025

Late-Breaking Data on Tapinarof Cream for Atopic Dermatitis, with Linda Stein Gold, MD

Latest News

Latest Article

Latest Conferences

Latest Webinars

Whats more on Hidoc Dr.

News

Quizzes

Surveys

Conferences

Reach us

Hidoc Dr. Features